Lv2
158 积分 2022-06-22 加入
Hypoxia-Responsive CAR-T Cells Exhibit Reduced Exhaustion and Enhanced Efficacy in Solid Tumors
9小时前
已完结
Allogeneic CD19-targeting T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial
9小时前
已完结
Bispecific killer cell engager-secreting CAR-T cells redirect natural killer specificity to enhance antitumour responses
1天前
已完结
Eradicating Drug Tolerant Persister Cells in EGFR-Mutated Non-Small Cell Lung Cancer by Targeting TROP2 with CAR-T cellular therapy
18天前
已完结
Phase I Trial of Anti‐PSMA Designer CAR‐T Cells in Prostate Cancer: Possible Role for Interacting Interleukin 2‐T Cell Pharmacodynamics as a Determinant of Clinical Response
20天前
已完结
Safety and activity of CTX130, a CD70-targeted allogeneic CRISPR-Cas9-engineered CAR T-cell therapy, in patients with relapsed or refractory T-cell malignancies (COBALT-LYM): a single-arm, open-label, phase 1, dose-escalation study
21天前
已完结
Allogeneic CD19-targeted CAR-T therapy in patients with severe myositis and systemic sclerosis
21天前
已完结
De novo-designed pMHC binders facilitate T cell–mediated cytotoxicity toward cancer cells
1个月前
已关闭
De novo design and structure of a peptide–centric TCR mimic binding module
1个月前
已完结
De novo design and structure of a peptide–centric TCR mimic binding module
1个月前
已完结
皖公网安备34019202002308
